Skip to main content
Euromedis Groupe logo

Euromedis Groupe — Investor Relations & Filings

Ticker · ALEMG ISIN · FR0000075343 LEI · 9695004RFDS89YEZN363 PA Human health and social work activities
Open in API
Filings indexed 192 across all filing types
Latest filing 2026-04-24 Earnings Release
Country FR France
Listing PA ALEMG

About Euromedis Groupe

https://www.euromedis.fr

Euromedis Groupe specializes in the design, manufacturing, distribution, and rental of medical equipment and single-use devices. The company's product portfolio includes sterile and non-sterile medical gloves, dressings, compresses, diagnostics, and various hygiene-related products. It also provides solutions for the home care market, such as oxygen therapy and incontinence products. Euromedis Groupe serves a diverse client base, including hospitals, clinics, and other healthcare professionals, distributing products under its own brand name.

Recent filings

Filing Released Lang Actions
Laboratoires Euromedis - Communiqué résultat 2025
Earnings Release Classification · 1% confidence The document is a press release titled “Résultats annuels 2025” summarizing the full-year financial results, key highlights, and outlook. It is concise (≈4,000 characters), provides high-level financial metrics, a brief operational commentary, and next-date announcements. This matches the definition of an Earnings Release (ER), rather than a full Annual Report (10-K) or Management Discussion (MDA). FY 2025
2026-04-24 French
LABORATOIRES EUROMEDIS - RAPPORT FINANCIER SEMESTRIEL 2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'RAPPORT FINANCIER SEMESTRIEL' (Half-Year Financial Report) for the period ending June 30, 2025. It contains a detailed management report, balance sheet, income statement, statement of changes in equity, and comprehensive notes to the financial statements. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-10-31 French
Rapport Financier Semestriel - 30/06/2025
Interim / Quarterly Report Classification · 1% confidence The document is titled 'RAPPORT FINANCIER SEMESTRIEL' (Half-Year Financial Report) for the period ending June 30, 2025. It contains a comprehensive set of financial statements, including a balance sheet, income statement, statement of changes in equity, and detailed notes to the financial statements. It is not an announcement or a summary, but the full interim report itself, which fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-10-31 French
Euromedis - Communiqué semestriel 2025
Earnings Release Classification · 1% confidence The document is a press release titled 'Résultats semestriels 2025' (2025 Half-Year Results). It provides a summary of financial performance, including revenue, gross margin, EBITDA, and net income for the first half of 2025 compared to 2024, along with a management outlook. While it contains financial data, it is a summary release (communique de presse) rather than a full, comprehensive interim report. According to the definitions, an Earnings Release (ER) is the initial announcement of quarterly/periodical financial results containing key highlights, which matches this document perfectly. H1 2025
2025-10-31 French
Euromedis - Communiqué résultat 2024
Earnings Release Classification · 1% confidence The document is a press release titled 'Résultats annuels 2024' (Annual Results 2024) issued by the company on April 25, 2025. It provides a summary of key financial highlights, including revenue, operating results, and net income, along with management commentary on business activities and future outlook. While it contains financial data, it is a short, high-level summary (Earnings Release) rather than a full, comprehensive Annual Report (10-K). Therefore, it fits the definition of an Earnings Release (ER). FY 2024
2025-04-25 French
LABORATOIRES EUROMEDIS - Ajustement du contrat de liquidité
Capital/Financing Update Classification · 1% confidence The document is very short (875 characters) and announces a modification to a liquidity contract ('contrat de liquidité') involving the withdrawal of 8,000 shares. It references regulatory changes (AMF decision) and provides a snapshot of the liquidity account balance as of the annual review date (June 30, 2024). This action—modifying or executing a liquidity contract, which involves managing the company's own shares for market stability—is most closely related to capital structure management or share transactions. Since there is no specific category for 'Liquidity Contract Modification,' the closest fit is 'Transaction in Own Shares' (POS), as the action involves withdrawing shares from the liquidity pool. It is not a full financial report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), but a specific corporate action regarding its own stock.
2024-12-10 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.